Our data suggest dynamic inverse regulation of GLP-1 and GLP-2 during liver regeneration, rather caused by an increase in expression/release than by changes in degradation capacity and might be associated with inflammatory responses
The most important and most frequently used indication for DPP-4 inhibitors is their add-on use in patients who are not sufficiently controlled on metformin monotherapy ( DPP-4 inhibitors can be administered in patients with impaired kidney function due to the good safety and tolerability
T.et al (2012)
Clinically meaningful interactions would not be expected with other sulfonylureas (e.g., glipizide, tolbutamide, and glimepiride) which, like glyburide, are primarily eliminated by CYP2C9
Notably, the FDG tracer, a glucose analogue, is exquisitely sensitive to metabolic perturbations
However, they activate receptors through similar mechanisms [12]